- Drugs
- Friday, 15 May 2020
Sanofi says COVID-19 vaccine will be available globally at the same time
Sanofi will ensure that a potential vaccine against COVID-19, if approved, reaches all regions of the world at the same time, the chairman of the French drugmaker said on Thursday.
“There will be no particular advance given to any country,” Serge Weinberg told France 2 television.
“We are organised with several manufacturing units. Some of them are in the United States but even more of them are in Europe and France,” he said.
Sanofi operates 73 industrial locations in 32 countries. There is no vaccine approved yet against COVID-19, the illness caused by the new coronavirus.
The group’s chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world, after angering the French government earlier by saying the United States would get priority access.
Related Industry Updates
Cannabis Market is Heating Up Faster Than Branders Can Define It
Oct 10, 2019
Kinderfarms Announces Kinderlyte® Advanced, Provides Natural Rehydration for Adults and Children
Mar 02, 2020
Drug Discovery Services Market is expected to reach US$ 56,783.29 million by 2030
Nov 17, 2023
Alligator Bioscience Presents Promising Interim Phase I Data for its Bispecific Drug Candidate ATOR-1015 at AACR
Apr 27, 2020
Advancements in Healthcare industry is driving More R & D for Subcutaneous Drug Delivery
Oct 04, 2019
Clinic Casting and Splinting Products Market is expected to reach US$ 2,085.57 million by 2030
Aug 02, 2023
Algae Products Market 2021 Growth, Demand, And Value Is Increasing In The Upcoming Years
Mar 23, 2021
Follow us on
